State of Wisconsin Investment Board
DRNA

State of Wisconsin Investment Board’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

State of Wisconsin Investment Board’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-88,700
Closed -$1.79M – 2267
2021
Q3 		$1.79M Hold
88,700
– – ﹤0.01% 1307
2021
Q2 		$3.31M Hold
88,700
– – 0.01% 1170
2021
Q1 		$2.27M Sell
88,700
-4,000
-4% -$102K ﹤0.01% 1217
2020
Q4 		$2.04M Sell
92,700
-11,500
-11% -$253K ﹤0.01% 1196
2020
Q3 		$1.88M Buy
104,200
+21,500
+26% +$445K ﹤0.01% 1171
2020
Q2 		$2.1M Buy
82,700
+2,800
+4% +$60.3K 0.01% 1115
2020
Q1 		$1.47M Buy
79,900
+2,200
+3% +$42.8K ﹤0.01% 1131
2019
Q4 		$1.71M Hold
77,700
– – ﹤0.01% 1157
2019
Q3 		$1.12M Buy
77,700
+2,100
+3% +$30K ﹤0.01% 1113
2019
Q2 		$1.19M Buy
75,600
+1,700
+2% +$23.1K ﹤0.01% 1096
2019
Q1 		$1.08M Buy
73,900
+26,900
+57% +$309K ﹤0.01% 1142
2018
Q4 		$502K Buy
47,000
+2,800
+6% +$36.8K ﹤0.01% 1311
2018
Q3 		$674K Hold
44,200
– – ﹤0.01% 1328
2018
Q2 		$541K Buy
+44,200
New +$555K ﹤0.01% 1351

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

State of Wisconsin Investment Board's DRNA Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 88,700 shares — an estimated $1.79M sold.

State of Wisconsin Investment Board first reported a position in DRNA in Q2 2018 and held it in 14 quarters. The position peaked at $3.31M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • State of Wisconsin Investment Board reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 88,700 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.79M.
  • State of Wisconsin Investment Board first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 14 quarters.
  • State of Wisconsin Investment Board's Dicerna Pharmaceuticals, Inc. position peaked at $3.31M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.